Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters-Reference-Cited by-同舟云学术

Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters

Published:2012-10-22 Issue:4 Volume:56 Page:488-495
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Lee Nan-Yao,Lee Ching-Chi,Huang Wei-Han,Tsui Ko-Chung,Hsueh Po-Ren,Ko Wen-Chien

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/56/4/488/17850007/cis916.pdf

Reference31 articles.

1. Resistance in gram-negative bacteria: Enterobacteriaceae;Paterson;Am J Med,2006

2. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis;Schwaber;J Antimicrob Chemother,2007

3. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern;Pitout;Lancet Infect Dis,2008

4. Extended-spectrum beta-lactamases and clinical outcomes: current data;Ramphal;Clin Infect Dis,2006

5. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii;Corbella;J Clin Microbiol,2000

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study;The Lancet Infectious Diseases;2024-08

2. Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?;Clinical Infectious Diseases;2023-11-16

3. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients;Transplant Infectious Disease;2023-10-20

4. Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review;Antibiotics;2023-07-31

5. Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians;Journal of Antimicrobial Chemotherapy;2023-07-31